Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 124

    1.

    Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND).

    Parhofer KG, Birkeland KI, Defronzo R, Del Prato S, Bhaumik A, Ptaszynska A.

    Int J Clin Pract. 2009 Nov 19. [Epub ahead of print]PMID: 19929980 [PubMed - as supplied by publisher]Related articles

    2.

    In Germany Diabetic Patients with Coronary Artery Disease are Treated More Intensively than Diabetic Patients with Other Manifestations of Atherothrombosis - Results from the REACH Registry.

    Parhofer KG, Zeymer U, Stark RG, Binz C, Schwertfeger M, Bhatt DL, Steg PG, Röther J.

    Exp Clin Endocrinol Diabetes. 2009 Oct 15. [Epub ahead of print]PMID: 19834877 [PubMed - as supplied by publisher]Related articles

    3.

    [Reduced bone density and bone pain : Osteomalacia with hypophospatemia and hypophosphaturia.]

    Findeisen HM, Auernhammer CJ, Parhofer KG, Herrmann KA, la Fougere C, Weiler C, Bartl R, Koch E.

    Internist (Berl). 2009 Sep 10. [Epub ahead of print] German. PMID: 19756443 [PubMed - as supplied by publisher]Related articles

    4.

    MMP-1 serum levels predict coronary atherosclerosis in humans.

    Lehrke M, Greif M, Broedl UC, Lebherz C, Laubender RP, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Göke B, Steinbeck G, Leber AW, Parhofer KG.

    Cardiovasc Diabetol. 2009 Sep 14;8:50.PMID: 19751510 [PubMed - in process]Related articlesFree article

    5.

    Risk Factors and Event Rates in Patients With Atherothrombotic Disease in Germany: Results of the REACH Registry.

    Zeymer U, Senges J, Parhofer KG, Röther J.

    Dtsch Arztebl Int. 2008 Nov;105(45):769-75. Epub 2008 Nov 7.PMID: 19578408 [PubMed - in process]Related articlesFree article

    6.

    BMI and hyperinsulinemia in children.

    Vogeser M, Schwandt P, Haas GM, Broedl UC, Lehrke M, Parhofer KG.

    Clin Biochem. 2009 Sep;42(13-14):1427-30. Epub 2009 Jun 25.PMID: 19560447 [PubMed - in process]Related articles

    7.

    [Statines for all or individualized lipid lowering therapy?]

    Parhofer K.

    MMW Fortschr Med. 2009 Apr 2;151(14):100, 102-4; quiz 105. German. No abstract available. PMID: 19504849 [PubMed - indexed for MEDLINE]Related articles

    8.

    Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

    Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC.

    Eur J Endocrinol. 2009 Aug;161(2):339-44. Epub 2009 Jun 4.PMID: 19497986 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cisplatin-based chemotherapy for pulmonary metastasized germ cell tumors of the testis--be aware of acute respiratory distress syndrome.

    Boeck S, Metzeler KH, Hausmann A, Baumann A, Gallmeier E, Parhofer KG, Stemmler HJ.

    Onkologie. 2009 Mar;32(3):125-8. Epub 2009 Feb 18.PMID: 19295253 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.

    Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, Göke B, Parhofer KG, Leber AW.

    PLoS One. 2009;4(3):e4733. Epub 2009 Mar 6.PMID: 19266101 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.

    Pusl T, Broedl UC, Parhofer KG, Otto C.

    Clin Hemorheol Microcirc. 2009;41(2):137-42.PMID: 19252236 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy]

    Hüttl TP, Obeidat FW, Parhofer KG, Zügel N, Hüttl PE, Jauch KW, Lang RA.

    Zentralbl Chir. 2009 Feb;134(1):24-31. Epub 2009 Feb 25. Review. German. PMID: 19242879 [PubMed - indexed for MEDLINE]Related articles

    13.

    Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.

    Jaeger BR, Richter Y, Nagel D, Heigl F, Vogt A, Roeseler E, Parhofer K, Ramlow W, Koch M, Utermann G, Labarrere CA, Seidel D; Group of Clinical Investigators.

    Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):229-39.PMID: 19234501 [PubMed - indexed for MEDLINE]Related articles

    14.

    Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.

    Metzeler KH, Boeck S, Christ B, Hausmann A, Stemmler HJ, Parhofer KG, Ostermann H, Hiddemann W, Braess J.

    Leuk Res. 2009 Jul;33(7):e69-72. Epub 2009 Feb 23. Review. No abstract available. PMID: 19230970 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis.

    Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, Tittus J, Parhofer K, Becker C, Reiser M, Knez A, Leber AW.

    Arterioscler Thromb Vasc Biol. 2009 May;29(5):781-6. Epub 2009 Feb 19.PMID: 19229071 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.

    Zeymer U, Parhofer KG, Pittrow D, Binz C, Schwertfeger M, Limbourg T, Röther J.

    Clin Res Cardiol. 2009 Apr;98(4):249-56. Epub 2009 Feb 16.PMID: 19221687 [PubMed - indexed for MEDLINE]Related articles

    17.

    Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography.

    Weckbach S, Findeisen HM, Schoenberg SO, Kramer H, Stark R, Clevert DA, Reiser MF, Parhofer KG.

    Invest Radiol. 2009 Apr;44(4):242-50.PMID: 19212269 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Treatment of hyperlipidemia in the elderly]

    Parhofer K.

    MMW Fortschr Med. 2008 Nov 20;150(47):31-3. German. No abstract available. PMID: 19189453 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Sequelae of the JUPITER study. What is changing in primary prevention? (interview by Dr. med. Dirk Einecke)]

    Parhofer K.

    MMW Fortschr Med. 2008 Dec 4;150(49-50):14. German. No abstract available. PMID: 19130769 [PubMed - indexed for MEDLINE]Related articles

    20.

    [25 years of progress in the treatment of metabolic disorders: statins revolutionise cardiovascular prevention]

    Parhofer K.

    MMW Fortschr Med. 2008 Nov 27;150(48):95, 98. German. No abstract available. PMID: 19125511 [PubMed - indexed for MEDLINE]Related articles

    21.

    Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.

    Lehrke M, Broedl UC, Biller-Friedmann IM, Vogeser M, Henschel V, Nassau K, Göke B, Kilger E, Parhofer KG.

    Crit Care. 2008;12(6):R157. Epub 2008 Dec 17.PMID: 19087258 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Adipokines and insulin resistance.

    Rabe K, Lehrke M, Parhofer KG, Broedl UC.

    Mol Med. 2008 Nov-Dec;14(11-12):741-51. Epub 2008 Sep 17. Review.PMID: 19009016 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Head-to-head comparison of an automated immunometric and an automated HPLC method for the quantification of HbA1c.

    Vogeser M, Parhofer KG.

    Clin Biochem. 2008 Nov;41(16-17):1410-2. Epub 2008 Sep 9.PMID: 18801350 [PubMed - indexed for MEDLINE]Related articles

    24.

    [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?]

    Broedl UC, Lehrke M, Parhofer KG.

    MMW Fortschr Med. 2008 Jun 19;150(25):41-3. German. No abstract available. PMID: 18705054 [PubMed - indexed for MEDLINE]Related articles

    25.

    Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.

    Lankat-Buttgereit B, Müller S, Schmidt H, Parhofer KG, Gress TM, Göke R.

    Biol Cell. 2008 Dec;100(12):703-15.PMID: 18549351 [PubMed - indexed for MEDLINE]Related articles

    26.

    Treatment of hypercholesterolemia.

    Parhofer KG.

    IDrugs. 1998 Nov;1(7):794-801.PMID: 18465648 [PubMed - in process]Related articles

    27.

    Comparison of automated insulin assays.

    Vogeser M, Parhofer KG.

    Clin Lab. 2007;53(9-12):557-60.PMID: 18257460 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Lower LDL and/or raise HDL. In what direction is lipidology moving?]

    Parhofer KG.

    MMW Fortschr Med. 2007 May 31;149(22):27. German. No abstract available. PMID: 18069222 [PubMed - indexed for MEDLINE]Related articles

    29.

    Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.

    Parhofer KG, Münzel F, Krekler M.

    Cardiovasc Diabetol. 2007 Nov 27;6:36.PMID: 18042288 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Resistin is an inflammatory marker of inflammatory bowel disease in humans.

    Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, Parhofer KG, Göke B, Broedl UC.

    Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1070-4.PMID: 17998831 [PubMed - indexed for MEDLINE]Related articles

    31.

    Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology.

    Vogeser M, Parhofer KG.

    Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):559-70. Review.PMID: 17943689 [PubMed - indexed for MEDLINE]Related articles

    32.

    Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.

    Otto C, Berster J, Otto B, Parhofer KG.

    J Clin Apher. 2007;22(6):301-5.PMID: 17935245 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Glucagon-like peptide 1 (GLP-1)]

    Parhofer KG.

    MMW Fortschr Med. 2007 Jun 21;149(25-26):41-3. German. PMID: 17713050 [PubMed - indexed for MEDLINE]Related articles

    34.

    [Cushing's syndrome with bilateral nodular adrenal enlargement]

    op den Winkel M, Auernhammer CJ, Jauch KW, Assmann G, Dietz C, Parhofer KG.

    Internist (Berl). 2007 Aug;48(8):870-3. German. PMID: 17605113 [PubMed - indexed for MEDLINE]Related articles

    35.

    Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.

    Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A.

    Clin Biochem. 2007 Sep;40(13-14):964-8. Epub 2007 Jun 2.PMID: 17583689 [PubMed - indexed for MEDLINE]Related articles

    36.

    Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia.

    Otto C, Otto B, Frost RJ, Vogeser M, Pfeiffer AF, Spranger J, Parhofer KG.

    Acta Diabetol. 2007 Jun;44(2):65-8. Epub 2007 May 27.PMID: 17530469 [PubMed - indexed for MEDLINE]Related articles

    37.

    Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.

    Julius U, Parhofer KG, Heibges A, Kurz S, Klingel R, Geiss HC.

    J Clin Apher. 2007;22(4):215-23.PMID: 17455220 [PubMed - indexed for MEDLINE]Related articles

    38.

    Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).

    Eur Heart J. 2007 Jan;28(1):88-136. No abstract available. PMID: 17220161 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.

    Hooper AJ, Robertson K, Barrett PH, Parhofer KG, van Bockxmeer FM, Burnett JR.

    J Clin Endocrinol Metab. 2007 Apr;92(4):1474-8. Epub 2007 Jan 9.PMID: 17213276 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.

    Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG, Konrad-Zerna A.

    Inflamm Bowel Dis. 2007 Apr;13(4):391-7.PMID: 17206692 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis.

    Pusl T, Denk GU, Parhofer KG, Beuers U.

    J Hepatol. 2006 Dec;45(6):887-91. Epub 2006 Sep 22.PMID: 17046095 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effect of a high-fat meal on the postprandial ghrelin response.

    Otto B, Heldwein W, Otto C, Huptas S, Parhofer KG.

    Am J Clin Nutr. 2006 Sep;84(3):664-5; author reply 665-6. No abstract available. PMID: 16960184 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects.

    Nagel JM, Tietz AB, Göke B, Parhofer KG.

    Metabolism. 2006 Sep;55(9):1149-54.PMID: 16919531 [PubMed - indexed for MEDLINE]Related articles

    44.

    Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

    Huptas S, Geiss HC, Otto C, Parhofer KG.

    Am J Cardiol. 2006 Jul 1;98(1):66-9. Epub 2006 May 4.PMID: 16784923 [PubMed - indexed for MEDLINE]Related articles

    45.

    Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever.

    Fraunberger P, Wang Y, Holler E, Parhofer KG, Nagel D, Walli AK, Seidel D.

    Shock. 2006 Jul;26(1):10-2.PMID: 16783191 [PubMed - indexed for MEDLINE]Related articles

    46.

    Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.

    Parhofer KG, Barrett PH.

    J Lipid Res. 2006 Aug;47(8):1620-30. Epub 2006 May 23. Review.PMID: 16720894 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.

    Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, Bollheimer LC.

    J Mol Endocrinol. 2006 Jun;36(3):485-501.PMID: 16720718 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.

    Broedl UC, Lehrke M, Fleischer-Brielmaier E, Tietz AB, Nagel JM, Göke B, Lohse P, Parhofer KG.

    Cardiovasc Diabetol. 2006 May 15;5:11.PMID: 16700915 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.

    Otto C, Otto B, Göke B, Pfeiffer AF, Lehrke M, Vogeser M, Spranger J, Parhofer KG.

    J Endocrinol Invest. 2006 Mar;29(3):231-6.PMID: 16682836 [PubMed - indexed for MEDLINE]Related articles

    50.

    [Diabetic dyslipoproteinemia]

    Geiss HC, Parhofer K.

    MMW Fortschr Med. 2006 Apr 6;148(14):30-3. German. PMID: 16669277 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...